Ballard Spahr assisted RhythMedix on the sale. Pharos Capital Group has acquired a majority stake in New Jersey-based RythMedix, a manufacturer and provider of remote cardiac…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
